Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of esketamine combined with remimazolam for painless bronchoscopy
ChiCTR2100049351Phase 4Not yet recruiting
- Sponsor
- Shandong Second People's Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and remimazolam (5 arms), sponsored by Shandong Second People's Hospital. Primary endpoints: mean arterial pressure, heart rate and 6 more. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
esketamineremimazolam
Beyond the preview
Go deeper on ChiCTR2100049351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049351.